γδ T Cells in Health and Disease Part B
- 1st Edition, Volume 398 - November 1, 2025
- Latest edition
- Editors: Carlos Jiménez-Cortegana, Claudia Galassi, Lorenzo Galluzzi
- Language: English
γδ T Cells in Health and Disease Part B, provides a comprehensive and up-to-date overview of the diverse roles that γδ T cells play in human physiology and pathology. This volume… Read more
γδ T Cells in Health and Disease Part B, provides a comprehensive and up-to-date overview of the diverse roles that γδ T cells play in human physiology and pathology. This volume builds on foundational knowledge to explore advanced topics and recent discoveries in γδ T cell biology, with a particular focus on their mechanisms of action, functional diversity, and implications for clinical practice.
- In-depth exploration of the molecular and cellular mechanisms underlying γδ T cell development, differentiation, and function
- Detailed analysis of the roles of γδ T cells in various disease contexts, including cancer, infectious diseases, autoimmune disorders, and inflammatory conditions
- Discussion of current and emerging therapeutic strategies targeting γδ T cells, including immunotherapy and adoptive cell transfer
Academic researchers, Clinical immunologists, Pharmaceutical and biotechnology professionals, Medical educators and faculty
1. Development of gd T cells
David Wiest
2. Human T-cell receptor inborn errors of immunity shed light on the real-life role of γδ vs αβ T lymphocytes
José R. Regueiro, Ana V Marin, Daniel Chacon-Arguedas, Ivan Estevez-Benito, Angela Zarco-Cuadrillero and Miguel Muñoz-Ruiz
3. Deciphering the Role of γδ T cells in Skin Inflammatory Diseases: Insights from Psoriasis, Atopic Dermatitis, and Alopecia Areata
Francisco Sánchez-Madrid
4. Role of gd T cells in zoonosis infection
Shovan Dutta, ANIRBAN GANGULY and Sounak Ghosh Roy
5. γδ T cells in Escherichia coli infection
Carolina Cristina Jancic
6. Gamma-delta T cells in breast cancer: dual role in tumor immunity and emerging therapeutic approaches
Luis de la Cruz-Merino
David Wiest
2. Human T-cell receptor inborn errors of immunity shed light on the real-life role of γδ vs αβ T lymphocytes
José R. Regueiro, Ana V Marin, Daniel Chacon-Arguedas, Ivan Estevez-Benito, Angela Zarco-Cuadrillero and Miguel Muñoz-Ruiz
3. Deciphering the Role of γδ T cells in Skin Inflammatory Diseases: Insights from Psoriasis, Atopic Dermatitis, and Alopecia Areata
Francisco Sánchez-Madrid
4. Role of gd T cells in zoonosis infection
Shovan Dutta, ANIRBAN GANGULY and Sounak Ghosh Roy
5. γδ T cells in Escherichia coli infection
Carolina Cristina Jancic
6. Gamma-delta T cells in breast cancer: dual role in tumor immunity and emerging therapeutic approaches
Luis de la Cruz-Merino
- Edition: 1
- Latest edition
- Volume: 398
- Published: November 1, 2025
- Language: English
CJ
Carlos Jiménez-Cortegana
Carlos Jiménez-Cortegana obtained the degree in Chemistry at University of Seville (Spain) in 2014. In July 2020 he got the PhD in Clinical Research at the same University, belonging to the group headed by Dr. Luis de la Cruz-Merino and Dr. Víctor Sánchez-Margalet. Currently, Carlos is a Postdoctoral Researcher at the Department of Radiation Oncology, Weill Cornell Medical College (New York, USA), in the research group headed by Dr. Lorenzo Galluzzi. From 2021, Carlos has published more than 15 articles in recognized, international journals, some of them in high-impact factor journals, mainly focused on the immunosuppressive role of myeloid-derived suppressor cells in a variety of diseases, including breast cancer, diffuse large B-cell lymphoma, and COVID-19.
Affiliations and expertise
Radiation Oncology, Weill Cornell Medical College, New York, NY, USA; Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, University of Seville, Seville, SpainLG
Lorenzo Galluzzi
Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.
Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:
OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.
Affiliations and expertise
Assistant Professor of Cell Biology in Radiation Oncology, Department of Radiation Oncology, Weill Cornell Medical College, NY, USARead γδ T Cells in Health and Disease Part B on ScienceDirect